Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × Specimen Handling × Clear all

Sponsor

Conditions

Neoplasm Metastasis 7 Multiple Myeloma 7 Lung Neoplasms 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Neuroblastoma 5 Melanoma 5 Fallopian Tube Neoplasms 5 Burkitt Lymphoma 5 Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Wilms Tumor 3 Triple Negative Breast Neoplasms 3 Rhabdoid Tumor 3 Ovarian Neoplasms 3 Osteosarcoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Malignant Solid Neoplasm 3 Leukemia, Biphenotypic, Acute 3 Histiocytosis, Langerhans-Cell 3 Hepatoblastoma 3 Hematologic Neoplasms 3 Glioma 3 Ependymoma 3 Central Nervous System Neoplasms 3 Small Cell Lung Carcinoma 2

Interventions

fludarabine phosphate 27 Cyclophosphamide 24 Whole-Body Irradiation 19 Mycophenolic Acid 19 Tacrolimus 16 Busulfan 16 ruxolitinib 15 Peripheral Blood Stem Cell Transplantation 14 Antilymphocyte Serum 14 fludarabine 13 Melphalan 12 Cyclosporine 10 thymoglobulin 9 Methotrexate 9 Sirolimus 6 Etoposide 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 Azacitidine 4 pomalidomide 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 parsaclisib 2 itacitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡